A. Indicate by using the abbreviations respectively shown in square brackets, the legal classifications of the following drugs showing whether they are included in Part 1 of Schedule 10 to the Pharmacy and Poisons Regulations [P1], Part 2 of Schedule 10 to the Pharmacy and Poisons Regulations [P2], Schedule 1 to the Pharmacy and Poisons Regulations [S1], Schedule 3 to the Pharmacy and Poisons Regulations [S3], Part 1 of Schedule 1 to the Dangerous Drugs ordinance [P2DD], Schedule 1 to the Antibiotics Regulations [A], or none of the above [NP ]:

(1 mark each)

a) A capsule containing 150 mg nilotinib

b) A tablet containing 500 mg levofloxacin

c) A syrup containing 10mg/5ml dextromethorphan HBr, 3.6 mg/5ml promethazine HCl, and 6.0 mg/5ml ephedrine HCl

d) A tablet containing 200 mg dried aluminium hydroxide gel, 200 mg magnesium hydroxide and 20 mg simethicone

e) A gel containing 0.33% brominidine

f) An oral suspension containing 100mg/5ml ibuprofen

g) An inhaler containing 50 mcg per actuation beclomethasone dipropionate

h) A solution for infusion containing 1g/100ml paracetamol

i) A syrup containing 1 mg/ketotifen

j) An eye drop containing 10 mg/g fusidic acid

k) A tablet containing 400 mg metronidazole

l) A capsule containing mebeverine

Note structure of mebeverine is:

m) A vial containing 50 mcg/ml sufentanil.

Note structure of sufentanil is:

B. Describe the specific conditions under which the following poisons would be exempted from the provisions of the Pharmacy and Poisons Ordinance as stipulated under regulation 8 of the Pharmacy and Poisons Regulations

a) Antihistamine (1 mark)

b) Lignocaine (1 mark)

c) Norethisterone (1 mark)

d) Sodium fluoride (4 marks)